Medullary thyroid carcinoma: 20 years experience Background: Medullary thyroid carcinoma (MTC) is a rare malignant tumor that arise from C cells. Surgical treatment and its results are controversial, so we decided to study it. Aim: To describe clinically MTC, treatment and outcomes in the long term. Material and Method: We retrospectively reviewed medical records of patients with MTC operated in our hospital between the years 1987 and 2007. We analyzed the clinical characteristics, treatment, morbidity and long-term follow up. Results: There were 24 patients operated with a mean age of 46.1 ± 16.6 years. The main form of presentation was painless increased cervical volume (56.2%). In 15% this pathology was part of a MEN 2b. All of them have had a total thyroidectomy, which was extended in 50% of cases. The 35.2% were multifocal, 29.4% bilateral and 62.5% had metastatic lymph node involvement. Five patients remained higher calcitonin levels in the postoperative period and 9 patients recurred clinically on average 4.5 years after surgery. The presence of persistent disease was significantly associated with hereditary MTC (p = 0.0088) and the clinical recurrence was significantly determined by the presence of not expanded total thyroidectomy (p = 0.0196). The probability of surviving more than 19 years was 66.6% (95% CI = 0.24 to 0.89). Conclusions: The MTC is a rare tumour and treatment of choice is surgery. The persistent disease is associated with hereditary MTC form, and the clinical recurrence is associated with not expanded total thyroidectomy. We recommend total thyroidectomy with central voiding and radical modified jugular dissection.
RESUMENIntroducción: En tiroidectomía total se están evaluando métodos de hemostasia distintos a la ligadura habitual. Objetivo: Presentar nuestra experiencia inicial en la tiroidectomía total sin ligaduras, al utilizar el método de sellado de vasos a través de Ligasure Precise ® . Material y método: Se consignaron en forma prospectiva, los datos de 129 pacientes: Datos personales, fecha de operación, antecedentes mórbidos, síntomas, función tiroidea, examen físico, ecografía, punción con aguja fina, tipo de operación, cirujano, tiempo operatorio, estadía postoperatoria, débito de drenajes, biopsia intraoperatoria y definitiva, complicaciones. Se utilizó un p < 0.05 como significativo para los cálculos estadísticos. Resultados: Se realizaron 129 tiroidectomías entre Enero y Agosto del 2005. Se operaron 65 pacientes de forma tradicional y 64 con Ligasure. No hubo mortalidad operatoria. Edad promedio 42,7 y 46,9 para cada grupo (p >0.05). Biopsia definitiva informó carcinoma en 34 y 32 % respectivamente. Hospitalización promedio de 2,63 días y 2,26 días (p 0.02). El débito de drenajes fue 78 cc para el grupo Ligasure y 63,2 cc para el grupo tradicional. Tiempo operatorio promedio de 94 minutos (grupo tradicional) y 92 minutos (Ligasure) (p= 0.6). Las complicaciones fueron hematoma (1 caso por grupo), Lesión de recurrente laríngeo (1 caso en el grupo de ligadura tradicional) e hipocalcemia transitoria (6 casos en el grupo Ligasure y 1 caso en el grupo control). Conclusión: La tiroidectomía con Ligasure Precise es un método cómodo para el cirujano y tan seguro como la tiroidectomía con ligaduras. Su aplicación, indicación y reales beneficios deben ser evaluados en el futuro con mayor número de casos.PALABRAS CLAVE: Tiroidectomía, Ligasure, hemostasia. SUMMARYBackground: Traditionally, hemostasis during thyroidectomy is done using clamp ligation of vessels. There is a new hemostasis method based on thermal coagulation and pressure that be used in this type of surgery. Aim: To report the experience with Ligasure Precise ® thermal hemostasis system. Material and methods: Prospective evaluation of patients subjected to thyroidectomy with or without the use of Ligasure ® . The choice of patients for each type of hemostasis was not randomized. Operative time, surgical complications and postoperative evolution were assessed. Results: During the study period, 64 patients
thyroglossal duct cyst with papillary carcinoma introduction: In about 1-2% of cases of thyroglossal cyst may be neoplastic changes, mostly correspond to papillary thyroid carcinoma (75-85%). The aim of this paper is to present 9 cases of papillary thyroid carcinoma in thyroglossal duct cyst. Materials and Methods: Data were recorded retrospectively from patients diagnosed with papillary thyroid carcinoma in thyroglossal duct cyst treated at Hospital Clínico Universidad de Chile between 1999-2014. results: From 142 cases operated for thyroglossal duct cyst, 9 cases of papillary cancer (6.34%) were recorded. The average age was 32 years. The average diameter of the lesion was 4.4 cm (SD 2.2 cm). 8 patients underwent total thyroidectomy; a simultaneous thyroid cancer was diagnosed in 3 of them. In 6 cases was added iodine therapy. In only one patient a lymph nodal dissection was performed. We do not observe any surgical complication. A solid component in preoperative ultrasonographic study is suspicious of malignancy. The average follow-up time was 85 months. There is no recurrence or mortality in this group of patients. conclusions: Although the safest long-term management is Sistrunk surgery associated with thyroidectomy and radioiodine in selected cases, these patients must be evaluated by a multidisciplinary group and thyroidectomy should be considered in high surgical volume center, in order to minimize complications.
Ossifying fibromyxoid tumor of the neck. Case reportOssifying fibromyxoid tumor of soft parts in an uncommon tumor with a benign behavior but with a tendency to relapse. We report a 76 years old female presenting with a growing mass located in the anterior portion of the neck that was excised. The pathological study disclosed an anaplastic thyroid cancer. The patient received chemotherapy and was lost from follow up. Nine years later, she presented with progressive dysphagia. A neck CT scan showed a mass in the left thyroid base that completely included the cervical esophagus. The patient was operated and the mass was excised. The pathological diagnosis disclosed an ossifying fibromyxoid tumor.Key words: Ossifying fibromyxoid tumor, Anaplastic thyroid cancer. ResumenEl tumor fibromixoide osificante corresponde a una neoplasia infrecuente, de comportamiento benigno pero que presenta recurrencia en un tercio de los casos, comportándose como un sarcoma de bajo grado. Se reporta el caso de una paciente operada de tiroides en dos oportunidades en 9 años, cuyo diagnóstico final fue tumor fibromixoide osificante.Palabras clave: Tumor fibromixoide osificante, cáncer anaplásico de tiroides.
Primary thyroid lymphoma. Report of four cases Primary thyroid lymphoma is uncommon and usually of non-Hodgkin type. We report four female patients with thyroid lymphoma. A 81 year-old patient that was operated and received three cycles of chemotherapy and was lost from follow up. A 16 yearold patient that is operated and received full chemotherapy and was discharged free of disease. A 80 year-old patient that was operated and died due to a multiple organ failure, 50 days after hospital admission and a 54 year-old female that was operated but rejected chemotherapy and was lost from follow up (Rev Méd Chile 2009; 137: 928-35).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.